首页> 外文OA文献 >Erratum to: Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: Integrated results from three randomized, double-blind studies of denosumab and zoledronic acid (Support Care Cancer (2013) 21, (3497-3507) DOI: 10.1007/s00520-013-1932-2)

【2h】

Erratum to: Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: Integrated results from three randomized, double-blind studies of denosumab and zoledronic acid (Support Care Cancer (2013) 21, (3497-3507) DOI: 10.1007/s00520-013-1932-2)

机译：勘误至：晚期实体瘤和骨转移患者的疼痛和与健康相关的生活质量：地诺单抗和唑来膦酸的三项随机，双盲研究的综合结果（Support Care Cancer（2013）21，（3497-3507） DOI：10.1007 / s00520-013-1932-2）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

SCOPUS: er.j

机译：Scopus: 而.就

著录项

作者
von Moos, Roger; Body, Jean-Jacques; Egerdie, Blair B.; Stopeck, Alison; Brown, Janet J.E.; Damyanov, Danail D.; Fallowfield, Lesley J; Marx, Gavin G.; Cleeland, Charles; Patrick, Donald L; Palazzo, Felipe F.G.; Qian, Yi; Braun, Ada; Chung, Karen;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献

1. Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: Integrated results from three randomized, double-blind studies of denosumab and zoledronic acid [J] . VonMoosR., BodyJ.-J., EgerdieB., Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2013,第12期

机译：晚期实体瘤和骨转移患者的疼痛和与健康有关的生活质量：地诺单抗和唑来膦酸的三项随机双盲研究的综合结果
2. Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic Acid [J] . Cleeland Charles S., Body Jean-Jacques, Stopeck Alison, Cancer: A Journal of the American Cancer Society . 2013,第4期

机译：地诺单抗和唑来膦酸的随机双盲研究表明晚期乳腺癌和骨转移患者的疼痛结局
3. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. [J] . Henry DH, Costa L, Goldwasser F, Journal of Clinical Oncology . 2011,第9期

机译：地诺单抗和唑来膦酸在晚期癌症（乳腺癌和前列腺癌除外）或多发性骨髓瘤患者的骨转移治疗中的随机，双盲研究。
4. Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised crossover study of community vs hospital bisphosphonate administration [O] . A Wardley, N Davidson, P Barrett-Lee, 2005

机译：唑来膦酸显着改善患有骨转移的乳腺癌患者的疼痛评分和生活质量：社区与医院双磷酸盐治疗的随机交叉研究
5. Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study [O] . Karim Fizazi, Michael Carducci, Matthew Smith, 2011

机译：Denosumab与唑醇酸酸抗阉割前列腺癌中骨转移的影响：随机，双盲研究

Erratum to: Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: Integrated results from three randomized, double-blind studies of denosumab and zoledronic acid (Support Care Cancer (2013) 21, (3497-3507) DOI: 10.1007/s00520-013-1932-2)

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅